By: Tiantian Zhang1, Yiqun Han2, Lei Deng3 1. Department of Internal Medicine, University of Central Florida, Pensacola, FL 2. Mayo Clinic, Rochester, MN 3. University of Washington/Fred Hutch Cancer Center, Seattle, WA
By Dr. Abhishek A. Mangaonkar Mayo Clinic The phase 2 FIGHT-203 trial (NCT#03011372) studied 28 patients with relapsed/refractory myeloid/lymphoid neoplasms with FGFR1 rearrangement. FGFR1 rearrangement should be suspected in patients who
More
Dr. Luke Fletcher Willamette Valley Cancer Institute & Research Center Philadelphia positive acute lymphoblastic leukemia treatment has been driven by the combination of tyrosine kinase inhibitors targeting BCR-ABL in conjunction with
More
Dr. Aditi Sharma of Barbara Ann Karmanos Cancer Institute & Dr. Abhishek Mangaonkar of Mayo Clinic In the phase III AGILE trial reported in the New England Journal of Medicine, Pau
More
By Luke Fletcher, MD Willamette Valley Cancer Institute & Research Center Imetelstat, a telomerase inhibitor, has shown interesting promise for ESA refractory or unlikely to respond low-risk Myelodysplastic syndrome (MDS). In
More
By Paolo Tarantino, MD Dana-Farber Cancer Institute/Harvard Medical School “Overall, a major shift in the way we treat breast cancer has occurred in 2022, with the demonstration that patients with tumors
More
Oncologists Interested in Improving Access to Cancer Care Encouraged to Apply Are you an oncologist who is passionate about educating fellow providers? We invite you to apply to join the Binaytara Foundation
More
ASH Review Portland, Highlights from SABCS, and Thoracic Oncology San Diego The Binaytara Foundation is facilitating three conferences with varying focuses at the beginning of the year. These meetings include BTF’s ASH
More
Meet Chris Nevala-Plagemann, MD, Katie Kerrigan, DO, and Theresa Werner, MD! In this week’s faculty highlight, we present Drs. Chris Nevala-Plagemann, Katie Kerrigan, and Theresa Werner. These three doctors joined us as
More
Senior Fellows and Early Career Oncologists Interested in Cancer Health Disparities are Encouraged to Apply Interested in being mentored by oncologists and writing conference summaries for publication in a peer-reviewed journal? Apply
More
Submit Your Research for Presentation at Our Cancer Disparities Summit The Binaytara Foundation invites you to submit your research for our Summit on Cancer Health Disparities (SCHD23) in Seattle, WA, on April
More